# Dual Antiplatelet Therapy Strategies After Acute Myocardial Infarction Undergoing PCI: Prasugrel vs Ticagrelor & 12 Months vs 1-3 Months

Study · id `cardio:ct-nct07507500` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07507500](<https://clinicaltrials.gov/study/NCT07507500>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07507500

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 8100 participants.

## Technical summary

Registry record NCT07507500. Randomized; single masking; primary purpose treatment. Start 2026-09-02 (actual); primary completion 2029-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 8100 participants (planned count; ClinicalTrials.gov record NCT07507500, source copy `cardio:ctgov-nct07507500-2026-09-09`, retrieved 2026-10-26)
- Started: 2026-09-02 (actual) (ClinicalTrials.gov record NCT07507500, source copy `cardio:ctgov-nct07507500-2026-09-09`, retrieved 2026-10-26)
- Primary completion: 2029-07 (anticipated) (ClinicalTrials.gov record NCT07507500, source copy `cardio:ctgov-nct07507500-2026-09-09`, retrieved 2026-10-26)
- Completion: 2030-01 (anticipated) (ClinicalTrials.gov record NCT07507500, source copy `cardio:ctgov-nct07507500-2026-09-09`, retrieved 2026-10-26)
- Countries: Ireland; Latvia; Norway; Poland; Spain (ClinicalTrials.gov record NCT07507500, source copy `cardio:ctgov-nct07507500-2026-09-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07507500-2026-09-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Dual Antiplatelet Therapy Strategies After Acute Myocardial Infarction Undergoing PCI: Prasugrel vs Ticagrelor & 12 Months vs 1-3 Months
- Acronym: STREAMLINE
- Condition: Myocardial Infarction (MI)
- Intervention (Drug): Prasugrel
- Intervention (Drug): Ticagrelor
- Lead sponsor: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
- Lead sponsor class: OTHER
- Collaborator: Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry intervention name matches this record: Prasugrel (`cardio:prasugrel`)
- Registry intervention name matches this record: Ticagrelor (`cardio:ticagrelor`)
- Registry intervention is a member of this class by a sourced record link: P2Y12 inhibitors (drug class) (`cardio:p2y12-inhibitors`)
- Registry lists this organization as the lead sponsor: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz (`cardio:org-instituto-de-investigacion-sanitaria-de-la-fundacion-8312e5`)
- Registry lists this organization as a collaborator: Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III (`cardio:org-fundacion-centro-nacional-de-investigaciones-0f9f16`)

## Provenance

Content hash: 252c6c6436b72cf629babc11bc7146a388f9af68208770d8e8d4bf1c5120359a
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
